These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6522078)

  • 1. Use of continuous insulin infusion therapy to achieve improved metabolic control.
    Chiumello G; Meschi F; Beccaria L; Pellini C; di Natale B; Bianchi C
    Panminerva Med; 1984; 26(3):171-5. PubMed ID: 6522078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic control using a subcutaneous insulin infusion pump: effects 2 years after treatment].
    Goicolea Opacua I; Martínez Castillo A; Santamaría Pelarda E; Sola Sarabia C; Vázquez García JA
    Rev Clin Esp; 1988 Mar; 182(4):200-2. PubMed ID: 3045905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intensive insulin therapy in the diabetic child].
    Bougnères PF
    Union Med Can; 1985 Oct; 114(10):821-8. PubMed ID: 3909569
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetes and the insulin pump: functional results after 5 consecutive years of permanent use].
    Mirouze J; Rouault R; Misse P; Millet P; Bordat B; Selam JL; Boudet C
    Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):437-40. PubMed ID: 2598391
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive management of type 1 diabetes in young children.
    Kaufman FR
    Lancet; 2005 Feb 26-Mar 4; 365(9461):737-8. PubMed ID: 15733703
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of type I diabetes mellitus with continuous subcutaneous insulin infusion: indications and quality control].
    Berger M; Chantelau EA; Spraul M
    Verh Dtsch Ges Inn Med; 1989; 95():135-40. PubMed ID: 2603477
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion in a patient with partial endocrine pancreatic graft function.
    Giannarelli R; Aragona M; Coppelli A; Boggi U; Rizzo G; Marsocci A; Mosca F; Del Prato S; Marchetti P
    Transplant Proc; 2001; 33(7-8):3500-1. PubMed ID: 11750496
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-time continuous glucose monitoring in randomized control trials.
    Battelino T; Phillip M
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():401-4. PubMed ID: 20877253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial.
    de Beaufort CE; Houtzagers CM; Bruining GJ; Aarsen RS; den Boer NC; Grose WF; van Strik R; de Visser JJ
    Diabet Med; 1989 Dec; 6(9):766-71. PubMed ID: 2533034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetes and glucose monitoring.
    Bloomgarden ZT
    Diabetes Care; 2007 Nov; 30(11):2965-71. PubMed ID: 17965312
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus.
    Wang Y; Gong C; Cao B; Meng X; Wei L; Wu D; Liang X; Li W; Liu M; Gu Y; Su C
    Pediatr Diabetes; 2017 May; 18(3):196-203. PubMed ID: 26947770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Pump Adherence Behaviors Do Not Correlate With Glycemic Variability Among Youth With Type 1 Diabetes (T1D).
    Paprocki E; Staggs V; Patton S; Clements M
    J Diabetes Sci Technol; 2019 Jan; 13(1):142-143. PubMed ID: 30317860
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin pump with glucose sensor in type 1 diabetes. But the artificial pancreas is still far off].
    Moberg E
    Lakartidningen; 2010 Dec 8-14; 107(49):3120-1. PubMed ID: 21284143
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of improved glycemic control by continuous subcutaneous insulin infusion on hormonal responses to insulin-induced hypoglycemia in type 1 diabetics.
    Lins PE; Clausen N; Adamson U; Kollind M; Hamberger B; Efendic S
    Acta Med Scand; 1985; 218(1):111-8. PubMed ID: 4050545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pump therapy with continuous glucose monitoring improves metabolic control in brittle type 1 diabetes.
    Petrovski G; Dimitrovski C; Milenkovic T
    Prilozi; 2007 Jul; 28(1):129-35. PubMed ID: 17921923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 18. [Insulin therapy in 1984].
    Grimaldi A
    Ann Med Interne (Paris); 1984; 135(3):217-34. PubMed ID: 6378010
    [No Abstract]   [Full Text] [Related]  

  • 19. Six-Year Follow-Up After Insulin Pump Initiation: HbA1c Is Significantly Reduced Without Weight Gain.
    Andersen HU; Hangaard S; Hommel E; Ridderstråle M
    J Diabetes Sci Technol; 2018 Mar; 12(2):535-536. PubMed ID: 28927286
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic control is not altered when using indwelling catheters for insulin injections.
    Hanas SR; Ludvigsson J
    Diabetes Care; 1994 Jul; 17(7):716-8. PubMed ID: 7924783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.